Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature

BackgroundAlbeit the need for sex-disaggregated results of adverse events after immunization (AEFIs) is gaining attention since the COVID-19 pandemic, studies with emphasis on sexual dimorphism in response to COVID-19 vaccination are relatively scarce. This prospective cohort study aimed to assess d...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Janneke W. Duijster, Thomas Lieber, Silvia Pacelli, Leontine Van Balveren, Loes S. Ruijs, Monika Raethke, Agnes Kant, Florence Van Hunsel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Subjects:	COVID-19 vaccine sex adverse event after vaccination patient reported outcome pharmacovigilance longitudinal cohort design
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1078736/full

Similar Items

Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands
by: Monika Raethke, et al.
Published: (2025-07-01)

A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemic
by: Florence van Hunsel, et al.
Published: (2025-08-01)

Timing Matters: Exploring the Role of the Time to Onset in Recall Bias for Adverse Events Following Immunization (AEFIs) of COVID-19 Vaccines from Spontaneous Reports
by: Joep Scholl, et al.
Published: (2025-04-01)

Sex, Age, and COVID-19 Vaccine Characteristics Associated with Adverse Events After Vaccination and Severity: A Retrospective Analysis
by: Edgar P. Rodríguez-Vidales, et al.
Published: (2025-09-01)

A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults
by: Beniamino Cappelletti-Montano, et al.
Published: (2023-06-01)

Intent to Be Vaccinated against COVID-19 in Victoria, Australia
by: Katherine Heath, et al.
Published: (2022-01-01)

Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system
by: Yuhang Zhou, et al.
Published: (2025-06-01)

Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023
by: Jinyoung Jeong, et al.
Published: (2025-04-01)

Assessment of Causality, Severity and Seriousness of Adverse Event Following Immunization in Iraq: A Retrospective Study Based on Iraqi
by: Ahmad K. Abd, et al.
Published: (2019-12-01)

Changes in intentions, behavior, and reasons to receive COVID-19 vaccination December 2020–August 2023
by: Yanhan Shen, et al.
Published: (2025-08-01)

Menstrual disorders following COVID-19 vaccination: a review using a systematic search
by: Veerle R. Smaardijk, et al.
Published: (2024-01-01)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
by: Yunha Noh, et al.
Published: (2023-06-01)

Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review
by: Hannah G Davies, et al.
Published: (2024-06-01)

Changes in Local and Systemic Adverse Effects following Primary and Booster Immunisation against COVID-19 in an Observational Cohort of Dutch Healthcare Workers Vaccinated with BNT162b2 (Comirnaty<sup>®</sup>)
by: Christiaan Serbanescu-Kele Apor de Zalán, et al.
Published: (2023-12-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017
by: Josiah Tatenda Masuka, et al.
Published: (2019-08-01)

Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications
by: Zia Ul Mustafa, et al.
Published: (2023-06-01)

DARE-SAFE: Denominator-Adjusted Rate Estimates of Substance Adverse Events Frequency Evaluation in Pharmaceuticals and Vaccines
by: Matthew Halma, et al.
Published: (2025-03-01)

Gerapporteerde klachten bij prematuren na vaccinatie binnen het Rijksvaccinatieprogramma
by: Sanne van den Berge - Boetzkes, et al.
Published: (2025-09-01)

Farmacovigilancia de vacunas y su aplicación en Chile
by: Adiela Saldaña, et al.
Published: (2020-05-01)

The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19
by: Izabela Jęśkowiak, et al.
Published: (2021-05-01)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
by: Milo Gatti, et al.
Published: (2021-01-01)

Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017–2018
by: Pasquale Stefanizzi, et al.
Published: (2019-10-01)

Incidence and Nature of Short-Term Adverse Events following COVID-19 Second Boosters: Insights from Taiwan’s Universal Vaccination Strategy
by: Ching-Hao Lin, et al.
Published: (2024-01-01)

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon
by: Abeer Zeitoun, et al.
Published: (2024-11-01)

Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database
by: Rita Karam, et al.
Published: (2024-10-01)

Latentietijden van vermoede bijwerkingen na BMR-vaccinatie in de spontane meldingen van Bijwerkingencentrum Lareb
by: Djurre van der Kooi, et al.
Published: (2025-07-01)

Real-world safety of HPV vaccines over 18 y: A comprehensive analysis of U.S. VAERS reports
by: Yonglong Su, et al.
Published: (2025-12-01)

SARS-CoV2 Vaccination Adverse Events Trend in Italy: A Retrospective Interpretation of the Last Year (December 2020–September 2021)
by: Nicola Di Fazio, et al.
Published: (2022-01-01)

A statistical study about vaccines used against Covid-19 in Nineveh Governorat Iraq
by: Khalidah Nayyef Mustafa
Published: (2024-12-01)

Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action
by: Beckie N. Tagbo, et al.
Published: (2025-06-01)

Disproportionality Analysis of the Five Most Widespread Neurological Effects of COVID-19 Vaccines from 2021 to 2023: Insights from EudraVigilance
by: Arturo Gómez López de las Huertas, et al.
Published: (2025-04-01)

Use of mobile technology for reporting the pharmacovigilance of vaccines in Panama
by: Xavier Sáez-Llorens, et al.
Published: (2025-05-01)

Follow-Up of Side Effects throughout the Entire Course of Coronavirus Vaccination
by: Mohanad Odeh, et al.
Published: (2023-03-01)

Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign—A Case of Measles–Rubella and Polio Vaccines
by: Dan Kajungu, et al.
Published: (2021-11-01)

Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea
by: Yeon-Kyeng Lee, et al.
Published: (2023-10-01)

The Implementation of the Professional Role of the Community Pharmacist in the Immunization Practices in Italy to Counteract Vaccine Hesitancy
by: Rosagemma Ciliberti, et al.
Published: (2020-08-01)

Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone
by: Thomas F, et al.
Published: (2024-06-01)

Convulsive syndrome in the post-vaccination period: is there a connection with the vaccine?
by: E. P. Nacharova, et al.
Published: (2021-01-01)

What Drives Vaccine Uptake?—Investigating the Application of the Health Belief Model Through a Longitudinal Cohort Study During the COVID-19 Pandemic in Victoria, Australia
by: Anita Voloshin, et al.
Published: (2025-09-01)